Carfilzomib, Cyclophosphamide, Dexamethasone in Multiple Myeloma

Clinical trial NCT03336073 · UNKNOWN

Trial details

NCT number: NCT03336073
Sponsor: PETHEMA Foundation
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2017-12-18
Primary completion: 2024-12-01
Enrollment: 199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.